Capital Fund Management S.A. Emergent Bio Solutions Inc. Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $675,589 - $1.21 Million	91,917 New	91,917 $675,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $335,603 - $598,039	-16,705 Reduced 19.16%	70,498 $1.48 Billion
Q2 2022 Aug 12, 2022	BUY	$27.42 - $43.63 $1.34 Million - $2.13 Million	48,773 Added 126.91%	87,203 $2.71 Million
Q1 2022 May 12, 2022	BUY	$36.48 - $52.22 $1.4 Million - $2.01 Million	38,430 New	38,430 $1.58 Million
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $1.21 Million - $1.6 Million	-24,219 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$56.61 - $80.46 $1.37 Million - $1.95 Million	24,219 New	24,219 $1.53 Million
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $1.72 Million - $2.42 Million	-21,726 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $1.78 Million - $2.93 Million	21,726 New	21,726 $2.24 Million

172

36.8M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.